• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Vori Health Secures $53M for Value-Based Musculoskeletal Care

by Syed Hamza Sohail 03/13/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

–  Vori Health, the nation’s pioneering physician-led solution for musculoskeletal care, is making waves in the healthcare industry and just announced a $53 million Series B funding round.

–  Led by NEA and with continued support from AlleyCorp, Intermountain Health’s Intermountain Ventures, Echo Health Ventures, and Max Ventures, this heavily oversubscribed round is a testament to Vori Health’s rapid growth and innovative care model. In just 18 months, the company has delivered remarkable clinical outcomes and significant cost savings for patients and partners alike, while achieving an 800% revenue increase.

Vori Health Secures Funding to Advance Value-Based Musculoskeletal Care

Vori Health, a physician-led musculoskeletal care provider founded by leading surgeons from Yale and Mayo Clinic, is transforming the U.S. healthcare landscape with its integrated virtual and in-person care model. By combining board-certified physicians, physical therapists, registered dietitians, and health coaches, Vori Health eliminates unnecessary interventions while improving clinical outcomes and reducing costs for employers and health plans.

Since securing Series A funding, the company’s physician-led approach has delivered remarkable results, including:

• 91.6% of patients reporting clinically significant pain improvement

• A 78-90% reduction in elective orthopedic surgeries

• A 42% decrease in opioid utilization

• Up to a 68% reduction in depression and anxiety among patients

The latest funding will accelerate Vori Health’s mission to expand value-based musculoskeletal care nationwide. Key initiatives include:

• Enhancing value-based care models by evolving toward advanced economic frameworks, including two-sided population health risk

• Investing in data analytics to refine risk stratification and improve targeted interventions for high-risk populations

• Advancing AI-powered technology to optimize clinical programs and expand access for patients, employers, and health plan partners

Dr. Ryan Grant, Co-Founder and CEO, emphasized that this investment reinforces the company’s vision of scalable, high-quality musculoskeletal care. The rapid adoption of Vori Health’s platform by Fortune 200 companies and national health plans underscores the demand for its comprehensive solutions.

With this capital infusion, Vori Health aims to redefine musculoskeletal treatment—ensuring it is more effective, accessible, and patient-centered. By optimizing outcomes, reducing unnecessary procedures, and enhancing the overall care experience, the company is leading a fundamental shift toward a more humane and efficient healthcare system.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Value-Based Care

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |